Debanjan Das

Debanjan Das

Company: Bayer

Job title: Senior Associate Director & Science Fellow, Global R&D

Seminars:

Designing Modified Release Formulations for Nasal Administration of Local, Systemic and Targeted Drug Molecules 2:30 pm

Consideration of critical formulation parameters to design modified release (immediate & delayed) dosage forms Evaluation of spray characteristics for targeted deposition in internal nasal structures Development of in vitro nasal permeation models with PAMPA & other artificial membranes for enhanced delivery Formulation attributes to enhance enhanced absorption for N2B delivery in olfactory regionRead more

day: Day 2

Roundtable: Innovations and Challenges in Mucoadhesive Systems for Nasal Drug Delivery 2:00 pm

Discussing advancements in mucoadhesive technologies to enhance nasal drug retention and absorption Identifying challenges related to formulation, adhesion, and patient tolerability Exploring regulatory considerations and testing methods for mucoadhesive-based nasal formulationsRead more

day: Day 2

Chair’s Opening Remarks 9:25 am

Read more

day: Day 2

Chair’s Closing Remarks 3:00 pm

Read more

day: Day 2

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.